Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current immunotherapy in multiple sclerosis

K Bashir1, J N Whitaker

  • 1Department of Neurology, University of Alabama at Birmingham 35233-7340, USA.

Immunology and Cell Biology
|April 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing rye seedlings with melatonin to thrive in repeated freeze-thaw cycles and aluminum chloride stress.

Functional plant biology : FPB·2026
Same author

Anxiety, depression and stress among internally displaced persons and host community in an armed conflict region: A comparative study.

Psychiatry research·2022
Same author

Defining sepsis on the wards: results of a multi-centre point-prevalence study comparing two sepsis definitions.

Anaesthesia·2017
Same author

Collaborative research in ophthalmology: the way forward?

Eye (London, England)·2017
Same author

Upregulation of RAD51 expression is associated with progression of thyroid carcinoma.

Experimental and molecular pathology·2017
Same author

Dynamics of occurrence of refractory coeliac disease and associated complications over 25 years.

Alimentary pharmacology & therapeutics·2016
Same journal

Multi-Omics Comes of Age: Immune Profiling of Human Aging.

Immunology and cell biology·2026
Same journal

Mechanisms of Therapeutic Resistance and Recent Advances in Glioblastoma Treatment.

Immunology and cell biology·2026
Same journal

Ancestry Matters in Decoding Immunity.

Immunology and cell biology·2026
Same journal

Improving COVID-19 Vaccine Uptake Among Ethnic Minority Communities in Wales: A Community-Based Approach.

Immunology and cell biology·2026
Same journal

4-1BB Expression and Signaling Regulates MAIT Cell Activation and Effector Functions.

Immunology and cell biology·2026
Same journal

Highlights of 2025: Advances in the T-Cell Regulation of Germinal Center Response.

Immunology and cell biology·2026
See all related articles

Multiple sclerosis (MS) is an autoimmune central nervous system disease. Current treatments focus on immune therapies, with recent successes offering hope for better management of this neurological disorder.

Area of Science:

  • Neuroimmunology
  • Central Nervous System Disorders

Background:

  • Multiple sclerosis (MS) is a prevalent central nervous system disease with presumed autoimmune pathophysiology.
  • Treatment strategies for MS have largely centered on immunosuppressive and immunomodulatory therapies.
  • Research into MS and its animal model, experimental allergic encephalomyelitis, involves diverse immunological investigations.

Purpose of the Study:

  • To review the current landscape of multiple sclerosis treatment.
  • To highlight the role of immune-mediated therapies in managing MS.
  • To discuss recent advancements and future prospects in MS therapeutics.

Main Methods:

  • Review of existing literature on multiple sclerosis pathophysiology and treatment.
  • Analysis of immune-mediated therapeutic approaches, including immunosuppressive and immunomodulatory drugs.

Related Experiment Videos

  • Examination of recent clinical trial successes and emerging therapeutic strategies.

    • Main Results:

    • Interferon beta and glatiramer acetate have shown success in treating relapsing-remitting MS.
    • The diverse immunological abnormalities in MS necessitate a broad range of drug testing.
    • Advances in clinical trial methodology and surrogate markers are facilitating progress.

    Conclusions:

    • Immune-mediated therapies are central to managing multiple sclerosis.
    • Recent therapeutic successes with interferon beta and glatiramer acetate have increased optimism for effective MS control.
    • Improved research methodologies and novel therapies promise accelerated advancements in treating this neurological disorder.